IRS Says Drug Co. Must Capitalize Voucher Costs
A pharmaceutical company that buys a voucher for expedited drug application review from another company must capitalize the costs to do so, the Internal Revenue Service's Office of Chief Counsel said in...To view the full article, register now.
Already a subscriber? Click here to view full article